Screener
GoodRx Holdings, Inc. GDRX Other revenue — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001809519-26-000152
| (in thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Prescription transactions revenue | $106,390 | $143,064 | $220,082 | $291,987 |
| Subscription revenue | 28,514 | 20,463 | 52,907 | 41,480 |
| Pharma Direct revenue | 61,628 | 34,981 | 113,858 | 63,629 |
| Other revenue | 3,879 | 4,562 | 7,570 | 8,944 |
| Total revenue | $200,411 | $203,070 | $394,417 | $406,040 |
Item 1. Financial Statements
FAQ
- What is GoodRx Holdings, Inc.'s other revenue — revenue?
- GoodRx Holdings, Inc. (GDRX) reported other revenue — revenue of $3.88M in Q2 2026.
- How has GoodRx Holdings, Inc.'s other revenue — revenue changed year-over-year?
- GoodRx Holdings, Inc.'s other revenue — revenue decreased by 15.0% year-over-year, from $4.56M to $3.88M.
- What is the long-term trend for GoodRx Holdings, Inc.'s other revenue — revenue?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s other revenue — revenue has grown at a -1.4% compound annual growth rate (CAGR), from $18.79M to $17.75M.
- What does other revenue — revenue mean?
- This metric represents revenue generated from ancillary business activities or secondary service offerings that fall outside of the company's primary prescription price comparison and pharmacy benefit manager-related operations. It captures diversified income streams that contribute to the overall digital healthcare platform ecosystem but are not core to the main transaction-based revenue model. Monitoring this segment helps investors assess the company's ability to monetize non-core assets and evaluate the scale of its secondary service portfolio.
Ask your AI about GoodRx Holdings, Inc.'s other revenue — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude